Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Kiniksa Pharmaceuticals, Ltd. (KNSA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 52 shares
@ $16.01, valued at
$832.5
Exercised 175 options to buy
@ $0 |
|
| 07/27/2023 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 5,200 shares
@ $18.01, valued at
$93.7k
Sold 16,168 shares
@ $19.25, valued at
$311.2k
Sold 7,632 shares
@ $19.69, valued at
$150.3k
Exercised 29,000 options to buy
@ $1.86, valued at
$53.9k
|
|
| 07/03/2023 |
4
| Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 07/03/2023 |
4
| McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 07/03/2023 |
4
| Levy Richard S (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 07/03/2023 |
4
| Popovits Kimberly J (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 07/03/2023 |
4
| Cole G Bradley (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 07/03/2023 |
4
| Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 06/08/2023 |
4
| BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 8,746 shares
@ $0
Granted 52,472 options to buy
@ $15.19, valued at
$797k
Granted 52,472 options to buy
@ $15.19, valued at
$797k
|
|
| 06/08/2023 |
4
| Malley Thomas (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Popovits Kimberly J (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Levy Richard S (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Cole G Bradley (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 06/08/2023 |
4
| McCain Tracey L (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 38,974 options to buy
@ $10.76, valued at
$419.4k
Granted 6,496 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 20,459 options to buy
@ $10.76, valued at
$220.1k
Granted 10,230 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Moat Ross (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 38,668 options to buy
@ $10.76, valued at
$416.1k
Granted 6,445 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Ragosa Mark (CFO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 42,050 options to buy
@ $10.76, valued at
$452.5k
Granted 7,000 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Tessari Eben (COO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 42,544 options to buy
@ $10.76, valued at
$457.8k
Granted 7,091 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 155,500 options to buy
@ $10.76, valued at
$1.7M
Granted 25,925 options to buy
@ $0 |
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 704 shares
@ $9.56, valued at
$6.7k
Paid exercise price by delivering 221 shares
@ $11.46, valued at
$2.5k
Paid exercise price by delivering 635 shares
@ $11.12, valued at
$7.1k
Exercised 774 options to buy
@ $0
Exercised 2,163 options to buy
@ $0 |
|
| 03/20/2023 |
4
| Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 1,929 shares
@ $11.46, valued at
$22.1k
Paid exercise price by delivering 3,523 shares
@ $11.12, valued at
$39.2k
Exercised 6,569 options to buy
@ $0
Exercised 12,002 options to buy
@ $0 |
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Megna Michael R (CHIEF ACCOUNTING OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 52 shares
@ $14.23, valued at
$740
Exercised 175 options to buy
@ $0 |
|
| 09/06/2022 |
4
| Moat Ross (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 360 shares
@ $9.56, valued at
$3.4k
Paid exercise price by delivering 563 shares
@ $11.44, valued at
$6.4k
Granted 59,460 options to buy
@ $11.97, valued at
$711.7k
Granted 9,908 options to buy
@ $0
Exercised 995 options to buy
@ $0 |
|
| 09/06/2022 |
4
| Patel Sanj K (CHAIRMAN & CEO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 1,929 shares
@ $11.44, valued at
$22.1k
Granted 239,795 options to buy
@ $11.97, valued at
$2.9M
Granted 39,967 options to buy
@ $0
Exercised 6,569 options to buy
@ $0 |
|
| 09/06/2022 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 507 shares
@ $11.44, valued at
$5.8k
Granted 59,930 options to buy
@ $11.97, valued at
$717.4k
Granted 9,990 options to buy
@ $0
Exercised 1,725 options to buy
@ $0 |
|
| 09/06/2022 |
4
| Ragosa Mark (CFO) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 547 shares
@ $11.44, valued at
$6.3k
Granted 64,660 options to buy
@ $11.97, valued at
$774k
Granted 10,777 options to buy
@ $0
Exercised 1,861 options to buy
@ $0 |
|
|
|
|